Evidence map›Paper›PMID 38088540›Full record

ArticlemBio2024

Identification of two anti-

Carla Bromuro, Brunella Posteraro, Rita Murri, Massimo Fantoni, Mario Tumbarello, Maurizio Sanguinetti, Rosanna Dattilo, Roberto Cauda, Antonio Cassone, Antonella Torosantucci

Abstract read
In one paragraph

Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Overview of Risk Factors and Diagnosis of Invasive Candidiasis.Journal of fungi (Basel, Switzerland) · 2026
    Review
  2. Serum Levels ofMicroorganisms · 2025
    Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Carla BromuroDipartimento di Malattie Infettive, Istituto Superiore di Sanità, Rome, Italy.
Brunella PosteraroDipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.ORCID 0000-0002-1663-7546
Rita MurriDipartimento Salute e Bioetica, Sezione Malattie Infettive, Università Cattolica del Sacro Cuore, Policlinico Universitario A. Gemelli IRCCS , Rome, Italy.
Massimo FantoniDipartimento Salute e Bioetica, Sezione Malattie Infettive, Università Cattolica del Sacro Cuore, Policlinico Universitario A. Gemelli IRCCS , Rome, Italy.
Mario TumbarelloDipartimento Biotecnologie Mediche, University of Siena, Siena, Italy.
Maurizio SanguinettiDipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.ORCID 0000-0002-9780-7059
Rosanna DattiloDipartimento di Malattie Infettive, Istituto Superiore di Sanità, Rome, Italy.
Roberto CaudaDipartimento Salute e Bioetica, Sezione Malattie Infettive, Università Cattolica del Sacro Cuore, Policlinico Universitario A. Gemelli IRCCS , Rome, Italy.
Antonio CassonePolo d'Innovazione della Genomica, Genetica e Biologia, Siena, Italy.ORCID 0000-0002-0434-0761
Antonella TorosantucciDipartimento di Malattie Infettive, Istituto Superiore di Sanità, Rome, Italy.ORCID 0000-0002-0074-4486

Funding

Italian Ministry of Health Grant N.50/RF-2016-02364901
6 · The paper itself

Abstract

importanceCandidemia (bloodstream invasion by

Indexed as

CandidemiaCandidiasis, InvasiveAntibodiesAntifungal AgentsAntigens, FungalCandidaHumansProspective StudiesAntibodiesAntifungal AgentsAntigens, Fungalantibody immunitycandidemiapatient survivalprotection

Identifiers

PMID38088540
PMCPMC10790786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.